These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9240085)

  • 21. Very fast cardiac imaging.
    Schwitter J; Sakuma H; Saeed M; Wendland MF; Higgins CB
    Magn Reson Imaging Clin N Am; 1996 May; 4(2):419-32. PubMed ID: 8724571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial contrast echocardiography: a new tool for assesment of myocardial perfusion.
    Chopra HK
    Indian Heart J; 2009; 61(1):8-13. PubMed ID: 19729683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance imaging for ischemic heart disease.
    Sakuma H
    J Magn Reson Imaging; 2007 Jul; 26(1):3-13. PubMed ID: 17659549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of transmural extent of infarction with contrast echocardiographically derived index of myocardial blood flow and myocardial blood volume fraction: comparison with contrast-enhanced magnetic resonance imaging.
    Choi EY; Seo HS; Park S; Kim HJ; Ahn JA; Ko YG; Choi BW; Kang SM; Choi D; Ha JW; Rim SJ; Jang Y; Chung N
    J Am Soc Echocardiogr; 2006 Oct; 19(10):1211-9. PubMed ID: 17000359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Regional myocardial perfusion in ischemic heart disease assessed by myocardial contrast echocardiography].
    Lim YJ; Nanto S; Ikeda T; Masuyama T; Matsumura Y; Mishima M; Kodama K; Kitabatake A; Inoue M
    J Cardiol; 1988 Mar; 18(1):21-30. PubMed ID: 3221311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis of congenital obstructive aortic arch anomalies in Chinese children by contrast-enhanced magnetic resonance angiography.
    Ming Z; Yumin Z; Yuhua L; Biao J; Aimin S; Qian W
    J Cardiovasc Magn Reson; 2006; 8(5):747-53. PubMed ID: 16891235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heart disease: functional evaluation with MR imaging.
    Higgins CB; Sakuma H
    Radiology; 1996 May; 199(2):307-15. PubMed ID: 8668769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection and quantification of coronary stenosis severity with myocardial contrast echocardiography.
    Wei K
    Prog Cardiovasc Dis; 2001; 44(2):81-100. PubMed ID: 11568821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
    Manka C; Träber F; Gieseke J; Schild HH; Kuhl CK
    Radiology; 2005 Mar; 234(3):869-77. PubMed ID: 15665227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mouse myocardial first-pass perfusion MR imaging.
    Coolen BF; Moonen RP; Paulis LE; Geelen T; Nicolay K; Strijkers GJ
    Magn Reson Med; 2010 Dec; 64(6):1658-63. PubMed ID: 20928892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic contrast-enhanced myocardial perfusion imaging using saturation-prepared TrueFISP.
    Schreiber WG; Schmitt M; Kalden P; Mohrs OK; Kreitner KF; Thelen M
    J Magn Reson Imaging; 2002 Dec; 16(6):641-52. PubMed ID: 12451577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
    Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
    Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New imaging technology: measurement of myocardial perfusion by contrast echocardiography.
    Rubin DN; Thomas JD
    Coron Artery Dis; 2000 May; 11(3):221-6. PubMed ID: 10832555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The developing role of magnetic resonance contrast media in the detection of ischemic heart disease.
    Saeed M; Wendland MF; Higgins CB
    Proc Soc Exp Biol Med; 1995 Mar; 208(3):238-54. PubMed ID: 7878062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantifying myocardial perfusion using contrast echocardiography.
    Galiuto L
    Heart; 2005 Feb; 91(2):133-5. PubMed ID: 15657212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promise and status of myocardial contrast-enhanced two-dimensional echocardiography: delineation of ischemic risk zone and quantitation of myocardial perfusion defects.
    Meerbaum S
    J Am Coll Cardiol; 1986 Feb; 7(2):395-6. PubMed ID: 3944360
    [No Abstract]   [Full Text] [Related]  

  • 37. [Contrast echocardiography and myocardial perfusion: what is the current status?].
    Roudaut R; Lafitte S; Laffort P; Labèque JN; Durrieu-Jaïs C; Coste P
    Ann Cardiol Angeiol (Paris); 1998 Nov; 47(9):668-72. PubMed ID: 9864567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New contrast agents and technologies for myocardial contrast echocardiography.
    Rovai D; Monaghan MJ
    Heart; 1997 Aug; 78 Suppl 1(Suppl 1):7-11. PubMed ID: 9301514
    [No Abstract]   [Full Text] [Related]  

  • 39. Assessment of myocardial perfusion abnormalities with contrast-enhanced two-dimensional echocardiography.
    Armstrong WF; Mueller TM; Kinney EL; Tickner EG; Dillon JC; Feigenbaum H
    Circulation; 1982 Jul; 66(1):166-73. PubMed ID: 7083503
    [No Abstract]   [Full Text] [Related]  

  • 40. Magnetic resonance imaging of microvascular leakage induced by myocardial contrast echocardiography in rats.
    Swanson SD; Dou C; Miller DL
    Magn Reson Imaging; 2006 Jun; 24(5):603-9. PubMed ID: 16735182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.